Search results
Results from the WOW.Com Content Network
[28] [29] IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles. [ 30 ] [ 31 ] The merger was completed in October and the resulting company was a $17.6 billion company called QuintilesIMS. [ 9 ]
JEPQ data by YCharts.. Long-term dividend yields. The monthly payouts added up to $5.38 per share over the last year, or a 10.7% yield against the current share price of approximately $58.
IMS Health's corporate headquarters is located in Danbury, Connecticut, United States. The company's chairman and CEO is Ari Bousbib. In 1998, the parent company, Cognizant Corporation, split into two companies: IMS Health and Nielsen Media Research. After this restructuring, Cognizant Technology Solutions became a public subsidiary of IMS Health
In its third quarter earnings report, it announced its 108th consecutive dividend increase. The company recently owned 15,450 properties across 90 different industries leased to more than 1,500 ...
Quintiles Announces Pricing of Initial Public Offering Stock Expected to Begin Trading on NYSE May 9th RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Quintiles today announced the pricing of its ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate
Traders work on the floor of the New York Stock Exchange during morning trading on Aug. 23, 2024, in New York City. (Michael M. Santiago/Getty Images) (Michael M. Santiago via Getty Images)
Monsanto Company Inc. 65 83 Bayer advanced talks with Monsanto's management and subsequently raised its off by $3 billion, to more than $65 billion - which represented a 2 percent increase on its previous offer. The eventual purchase price would be more than $66 billion. [22] [23] 9 2018 Takeda Pharmaceutical: Shire: 62.5 76